Wilma De Grava Kempinas is a biologist graduated from University of São Paulo (USP), where she also developed a postgraduate course in Morphology - Cell Biology at the Ribeirão Preto Medical School. The Post-Doctorate was completed in 1998, in the field of Reproductive Toxicology and Epididymal Biology, by the United States Environmental Protection Agency (US EPA). She worked as a Professor at São Paulo State University (UNESP) from 1988 to 2019 (Full Professor in Embryology since 2011). Since retirement, she has had a formal relationship with UNESP as a Volunteer Professor at the Institute of Biosciences of Botucatu (IBB), coordinating the Laboratory of Biology and Toxicology of Reproduction and Development (Reprotox). She advises the Postgraduate Program in General and Applied Biology at IBB. She is a member of the Society of Toxicology (SOT Full Member), International Neuroendocrinoly Federation and Brazilian Society of Toxicology. In addition to acting as Associate Editor of the international journals "Reproductive Toxicology" and "Drug and Chemical Toxicology", she belongs to the Editorial Board of important journals in the fields of Toxicology and Reproduction: Journal of Toxicology and Environmental Health, Toxicology, Journal of Applied Toxicology, Current Research in Toxicology and Animal Reproduction. She maintains scientific exchanges with researchers in Brazil, Chile, Argentina, the United States and Canada. The work carried out by the team she coordinates aims to investigate normal morphofunctional aspects and the effects of potentially toxic agents on the male and female reproductive systems, fertility, prenatal and postnatal development, using especially rodents as an experimental model. In an entrepreneurial approach, with the objective of collaborating with the social and environmental well-being, the generation of jobs and the sustainable economic development of the country, it develops research for the population control of animals, with the filing of a patent application at the INPI, and at the establishment of a male fertility biomarker.